Copyright
©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 493-502
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.493
Table 1 Patient characteristics
| Characteristic | n = 35 |
| Men | 29 (83%) |
| Age (mean ± SD) | 69 ± 12 yr |
| Hypertension | 33 (94%) |
| Hyperlipidemia | 25 (71%) |
| Diabetes | 14 (40%) |
| Smoking | 14 (40%) |
| Renal insufficiency | 14 (40%) |
| History of CHF | 6 (17%) |
| Prior MI | 20 (57%) |
| Ejection fraction (mean ± SD) | 43% ± 12% |
| Clinical presentation | |
| STEMI | 6 (17%) |
| NSTEMI | 14 (40%) |
| Unstable angina | 14 (40%) |
| Stable angina | 1 (3%) |
| Canadian heart class | |
| I, II | 0 |
| III | 7 (20%) |
| IV | 28 (80%) |
Table 2 Bypass graft characteristics
| Characteristic | n (%) |
| SVG age (mean ± SD) | 12.1 ± 5.1 yr |
| Prior PCI of SVG | 10 (29) |
| Grafted native vessel | |
| LAD | 9 (26) |
| LCx | 13 (37) |
| RCA | 10 (29) |
| Multiple | 3 (9) |
| Duration of graft occlusion | |
| Acute (< 24 h) | 12 (34) |
| Subacute (> 24 h to 30 d) | 9 (26) |
| Late (> 30 d) | 14 (40) |
Table 3 Procedural features and outcomes
| Feature | n (%) |
| Anticoagulation | |
| Heparin only | 12 (34) |
| Bivalirudin | 8 (23) |
| Heparin + GP IIb IIIa inhibitor | 15 (43) |
| Thrombectomy | 20 (57) |
| Distal protection device | 9 (26) |
| Number of stents (mean ± SD) | 2.1 ± 1.3 |
| Total stent length (mean ± SD) | 52 ± 35 mm |
| Stent type | |
| Drug-eluting | 19 (55) |
| Bare metal | 11 (31) |
| None | 5 (14) |
| Procedural outcome | |
| Success | 29 (83) |
| Failed | 6 (17) |
| Procedural complications | |
| Distal embolization | 1 (3) |
| No reflow | 5 (15) |
| In-hospital MACE | |
| Death | 2 (5.7) |
| Myocardial infarction | 1 (2.9) |
| Stroke | 0 |
| Repeat PCI or CABG | 0 |
| Any MACE | 3 (8.6) |
Table 4 Follow-up major adverse cardiac event
| MACE type | n (%) |
| Death | 5 (14) |
| Stroke | 1 (3) |
| MI | 15 (43) |
| Repeat bypass surgery | 0 |
| Repeat PCI | 6 (17) |
| Graft reocclusionAny MACE | 7 (20) 28 (80) |
- Citation: Nardone EW, Madsen BM, McCarey MM, Fischman DL, Ruggiero NJ, Walinsky P, Vishnevsky A, Savage MP. Percutaneous coronary intervention of totally occluded coronary venous bypass grafts: An exercise in futility? World J Cardiol 2021; 13(9): 493-502
- URL: https://www.wjgnet.com/1949-8462/full/v13/i9/493.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i9.493
